Lundbeck to Present New Clinical and Real-World VYEPTI®

Lundbeck to Present New Clinical and Real-World VYEPTI® (eptinezumab-jjmr) Data at the 65th Annual S

First-time presentation of a real-world evidence study that revealed high overall satisfaction with the effectiveness of VYEPTI treatment for chronic migraine among most patients and their treating neurologists, as well as positive infusion experienceHarris Poll Migraine Report Card Survey uncovers racial and ethnic...

Related Keywords

Texas , United States , Denmark , Italy , France , American , Marija Geertsen , Richard Lipton , Wade Cooper , Lundbeck , Linkedin , Drug Administration , American Migraine Foundation , Us Medical Affairs , National Institute Of Neurological Disorders , Twitter , Scientific Meeting Of The American Headache Society , Research To Practice , National Headache Foundation , Harris Poll Migraine Report Card , American Headache Society , Poll Migraine Report Card Survey , Annual Scientific Meeting , Vice President , Important Safety Information , Experiences With , Harris Poll Migraine Report Card Survey , Headache Related Stigma , Adults Experiencing High Frequency , High Acute Medication Use , Health Concerns , With Current Versus Previous High Frequency , Acute Medication Overuse , Long Term Effectiveness , Patients With Prior Preventive Migraine Treatment , Patients With Chronic Migraine , Patient Awareness , Provider Communication , Medication Overuse Headache Among Patients , Retrospective Cohort , Prescribing Information , Full Prescribing Information , Patient Information , Global Burden , Scientific Meeting June , Related Stigma , Medication Overuse Headache , Accessed May , Neurological Disorders , Disease Study , With Migraine , Finances From , Chronic Migraine Epidemiology ,

© 2025 Vimarsana